Monalizumab (Anti-Human CD159a)

Catalog No.A2053        Batch: A205303

Print

Technical Data

CAS No. 1228763-95-8
Formulation PBS Buffer, PH 7.4
Isotype Human IgG4-Kappa
Application Monalizumab (Anti-Human CD159a)
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Purity 99%
Protein concentration 7.72mg/ml
Endotoxin Level <1EU/mg

Biological Activity

Description Monalizumab (Anti-Human CD159a) is a novel, first-in-class humanized immunoglobulin G4 monoclonal antibody immune checkpoint inhibitor that targets the inhibitory CD94/NKG2A receptors.

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.